NAD disapproves of irrelevant images
This article was originally published in The Tan Sheet
Executive Summary
Brain Research Labs should discontinue use of before-and-after brain scans to demonstrate the efficacy of its cognitive supplement Procera AVH because the images demonstrate an ingredient's impact on the brain and not the supplement's impact, according to the National Advertising Division. NAD argues the images are irrelevant and do not accurately depict brain function or how the supplement works. Also, the images imply the product works immediately, which evidence does not support, the Council of Better Business Bureaus unit says. NAD also recommends the advertiser discontinue claims of "double proof of efficacy," because substantiation comes from one study. That study, however, adequately supports claims that use of Procera will "energize the brain, uplift mood, improve memory and sharpen the mind," and claims that Procera improves concentration and reduces hostility. Brain Research Labs voluntarily discontinued claims Procera improves IQ and reduces anxiety, according to NAD's Sept. 14 release
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.